The 1- and 3-year survival probabilities of patients on incident hemodialysis are dismal at 74% and 50%, respectively.[@bib1] Low body mass index (BMI),[@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7] muscle mass,[@bib4], [@bib8], [@bib9] percentage of body fat,[@bib9], [@bib10] history of weight loss,[@bib11], [@bib12] serum albumin,[@bib13], [@bib14] and total cholesterol levels[@bib15] are some of the strongest predictors of mortality in the population on maintenance hemodialysis (MHD). It is theorized that the previously described indicators of protein or energy depletion are the result of a wasting syndrome.[@bib16], [@bib17], [@bib18]

An expert panel of the International Society of Renal Nutrition and Metabolism (ISRNM) defined the protein-energy wasting (PEW) syndrome as "the state of decreased body stores of protein and energy fuels (that is, body protein and fat masses)."[@bib19] They also developed objective criteria for the clinical definition of the PEW syndrome in patients on dialysis and patients with chronic kidney disease (CKD) ([Table 1](#tbl1){ref-type="table"}).[@bib20] Although it has been considered that kidney disease, protein, or energy depletion is due to wasting and not decreased nutrient intake,[@bib17], [@bib21] the ISRNM panel included dietary protein (\<0.8 g/kg per day) and energy intakes (\<25 kcal/kg per day) as criteria for the PEW syndrome definition in patients on MHD. To our knowledge, the validity of these dietary definitions as indicators of the PEW syndrome has not been examined; therefore, we analyzed these in a retrospective analysis of the Hemodialysis (HEMO) study.[@bib22], [@bib23]Table 1International Society of Renal Nutrition and Metabolism Panel protein-energy wasting syndrome criteriaLow serum chemistrySerum albumin \<3.5 g/dl[a](#tbl1fna){ref-type="table-fn"}Serum cholesterol \<100 mg/dlLow body massBMI \<23 kg/m^2^Unintentional weight loss over time: 10% over 6 monthsBody fat percentage \<10%Low muscle massReduced mid-arm muscle circumference area (reduction \>10% in relation to 50th percentile of reference population)Low dietary intakeDPI \<0.60 g/kg/d in stage 2--5 CKD patients orDPI \<0.80 g/kg/d in MHD patientsDEI \<25 kcal/kg/d[^1][^2]

Materials and Methods {#sec1}
=====================

The details of the HEMO Study design were described elsewhere.[@bib22], [@bib23] In brief, the HEMO study was a 2-by-2 factorial design randomized control trial of standard- or high-dose hemodialysis and high- or low-flux dialyzers. Eligibility criteria were patients aged 18 to 80 years old who underwent in-center hemodialysis 3 times per week for ≥3 months. A total of 1846 participants were randomized in 15 clinical centers from March 1995 to October 2000, and followed until December 2001.

Trained study coordinators following standardized protocols conducted study visits. Demographics and comorbidity data were obtained with standardized questionnaires. The heights of the patients, obtained at study entry, and postdialysis weight measurements, obtained monthly, were used to calculate BMI. mid-arm muscle circumference was calculated from mid-arm circumference, and triceps skinfold thicknesses were measured with previously published protocols.[@bib24] Body fat percentage was calculated as: body fat percentage = (1.20 × BMI) + (0.23 × age) -- (10.8 × sex) − 5.4, (sex: females = 0, males = 1). Details of dietary assessment in the HEMO study were published elsewhere.[@bib25] Serum albumin was measured at a central laboratory by nephelometry. Equilibrated normalized protein catabolic rate (enPCR) were calculated from formal urea kinetic models using both single and double pool Kt/V urea. Total serum cholesterol was assessed locally at each clinical center laboratory.

Definitions of PEW syndrome individual criteria and categories are summarized in [Table 1](#tbl1){ref-type="table"}. Because the goal of the present analyses was to examine the relationships of baseline dietary protein intake (DPI) and dietary energy intake (DEI) with the rest of the PEW syndrome categories at month 12, the PEW syndrome at month 12 was defined as the presence of at least 1 criteria in 2 of the 3 nondietary categories (low serum chemistry, low body mass, or low muscle mass).

Statistical Methods {#sec1.1}
-------------------

Descriptive statistics for baseline clinical characteristics and month 12 PEW variables were reported as means, SDs, or medians, 25th and 75th percentiles for numeric variables, and proportions for categorical variables. Numeric and categorical variables were compared between the 2 groups or between quartiles of DPI and total protein intake using *t*-tests, 1-way analysis of variance, or χ^2^ tests as appropriate. Skewed variables were compared by a nonparametric equality-of-medians test.[@bib26]

### Associations of Baseline DPI and DEI With PEW Syndrome at Month 12 {#sec1.1.1}

Using the lowest quartiles as the reference, in separate logistic models, the presence of the PEW syndrome at month 12 was related to the second to fourth quartiles of baseline DPI and DEI. These models were adjusted for baseline age, sex, race, duration of end-stage renal disease, dialysis access, Kt/V group, flux group, smoking, alcohol use, diabetes, atherosclerotic conditions, congestive heart failure, cancer, and clinical center. The relationships of baseline DPI and DEI with the presence of the PEW syndrome at month 12 might have been driven by mathematical coupling (body weight is in the denominator of DPI and DEI and lower body weight is an indicator of the PEW syndrome); therefore, these models were repeated with additional adjustment for baseline postdialysis weight.

Furthermore, the relationships of baseline DPI and DEI with the presence of the PEW syndrome at month 12 could be nonlinear, with an increase in the odds of the PEW syndrome below a given threshold for DPI and DEI. To investigate this further, natural cubic spline regressions[@bib27], [@bib28] using 3 knots (placed as 0.48, 0.89, 1.50 g/kg per day for DPI and 11.7, 21.6, 36.3 kcal/kg per day for DEI) were performed to estimate odds ratio of the PEW syndrome at month 12 for continuous baseline values of DPI and DEI separately. These analyses included the same covariates as used in the analyses that compared DPI and DEI quartiles. Median values of DPI and DEI were used as reference values for expression of odds ratios. Although all available data were included in the spline regressions, we restricted graphic displays of the results of these analyses DPI and DEI values to between the 5th percentiles (0.38 g/kg per day for DPI and 9.6 kcal/kg per day for DEI) and the 95th percentiles (1.73 g/kg per day for DPI and 42.3 kcal/kg per day for DEI) in the respective baseline distributions, because spline regressions are unstable toward the extremes of the range of the predictor variable.

It could be argued that estimation of protein intake from diet might be unreliable. Therefore, in additional analyses, we used enPCR estimated from urea kinetics modeling as a measure of protein intake and repeated the preceding analyses. Urea kinetics modeling was carefully performed with a standardized protocol in the HEMO Study, and the details have been published elsewhere.[@bib22], [@bib23]

Results {#sec2}
=======

The baseline clinical characteristics by DPI and DEI groups are presented in [Table 2](#tbl2){ref-type="table"}. At baseline, 40.9% had DPI \<0.8 kg/kg per day and 64.4% had DEI \<25 kcal/kg per day. Those with lower DPI or DEI were older and more likely to be women. At baseline, lower DPI and lower DEI were associated with higher body weight.Table 2Baseline characteristics by dietary protein intake and dietary energy intake groups (N = 1487)Low DPI\
\<0.8 g/kg/d\
(*n* = 608)High DPI\
≥0.8 g/kg/d\
(*n* = 879)*P* valueLow DEI\
\<25 kcal/kg/d\
(*n* = 957)High DEI\
≥25 kcal/kg/d\
(*n* = 530)*P* valueAge (yr)59.1 ± 12.756.0 ± 14.8\<0.00159.4 ± 12.653.4 ± 15.7\<0.001Black (%)66.4%63.0%0.1867.2%59.4%0.003Male (%)35.4%49.5%\<0.00138.0%54.0%\<0.001ESRD duration (yr)2.0 (1.0, 4.1)2.3 (0.9, 5.2)0.102.0 (0.9, 3.9)2.7 (1.0, 6.5)0.001Fistula (%)28.5%38.7%\<0.00128.4%45.5%\<0.001Kt/V group (%)50.2%50.2%1.0049.8%50.8%0.74Flux group (%)51.5%49.9%0.5650.4%50.9%0.83Smoking (%)46.1%51.1%0.0647.2%52.3%0.06Alcohol use (%)14.5%16.8%0.2213.9%19.4%0.005Diabetes (%)51.5%37.4%\<0.00151.5%28.1%\<0.001Atherosclerotic conditions (%)45.7%39.1%0.0144.7%36.6%0.002Cancer (%)9.0%7.8%0.418.6%7.9%0.67Congestive heart failure (%)9.5%11.5%0.2310.9%10.4%0.77DPI (g/kg/d)0.62 (0.51, 0.71)1.10 (0.93, 1.36)\<0.0010.74 (0.58, 0.92)1.22 (1.02, 1.48)\<0.001DEI (kcal/kg/d)15.6 (12.4, 18.9)26.4 (21.4, 32.7)\<0.00117.6 (13.7, 21.2)31.3 (27.5, 37.1)\<0.001TPI (g/d)44.7 (37.2, 52.7)72.0 (62.2, 85.8)\<0.00152.1 (41.6, 66.2)74.4 (63.3, 89.6)\<0.001TEI (kcal/d)1162 (936, 1433)1692 (1401, 2048)\<0.0011225 (1012, 1497)1962 (1697, 2308)\<0.001enPCR (g/kg/d)0.98 (0.83, 1.14)1.04 (0.90, 1.22)\<0.0011.01 (0.86, 1.17)1.02 (0.88, 1.21)0.38Body weight (kg)75.1 (65.8, 85.1)63.8 (56.0, 72.3)\<0.00172.0 (63.0, 83.1)61.3 (54.0, 68.8)\<0.001[^3][^4]

The aim of the study was to examine the longitudinal associations of baseline dietary variables with the presence of the PEW syndrome at month 12. Furthermore, weight loss variables for PEW syndrome were defined by the baseline and 12-month postdialysis weights. Hence, the distribution of PEW variables at month 12 by DPI and DEI quartiles are listed in [Tables 3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}. As shown in [Figure 1](#fig1){ref-type="fig"}, the prevalence of PEW variables at month 12 varied considerably. Although the prevalence of a low BMI was 35.1%, no patients had a low percentage of body fat (\<10%).Figure 1Prevalence of protein-energy wasting (PEW) criteria at month 12 in the entire cohort (N = 1487). BMI, body mass index; MAMC, mid-arm mass circumference; Wt, weight.Table 3Month 12 distribution of PEW variables and the prevalence of PEW syndrome by baseline quartiles of DPI (g/kg/day) (N = 1487)Lowest quartile\
\<0.67 (*n* = 372)Second quartile\
0.67--0.88 (*n* = 371)Third quartile\
0.89--1.16 (*n* = 373)Highest quartile\
≥1.16 (*n* = 371)*P* valueSerum albumin (g/dl)3.5 ± 0.43.6 ± 0.43.6 ± 0.43.6 ± 0.40.003Serum cholesterol (mg/dl)173.3 ± 40.9169.5 ± 40.3163.4 ± 40.0159.0 ± 38.2\<0.001BMI (kg/m^2^)28.7 ± 5.726.6 ± 5.025.0 ± 4.222.3 ± 3.7\<0.001Weight change over 12 mo (%)−0.1 (−4.8, 2.7)−0.5 (−4.3, 3.7)0.5 (−2.8, 4.2)0.9 (−3.3, 5.1)0.008Body fat percentage38.9 ± 10.135.9 ± 9.132.5 ± 8.927.5 ± 8.3\<0.001MAMC (cm)26.5 ± 4.025.1 ± 3.724.6 ± 3.323.2 ± 3.3\<0.001Prevalence of PEW syndrome (%)13.716.422.539.4\<0.001[^5][^6]Table 4Month 12 distribution of PEW variables and the prevalence of PEW syndrome by baseline quartiles of DEI (kcal/kg/day) (N = 1487)Lowest quartile\
\<16.0 (*n* = 373)Second quartile\
16.0--21.7 (*n* = 371)Third quartile\
21.8--28.2 (*n* = 372)Highest quartile\
≥28.2 (*n* = 371)*P* valueSerum albumin (g/dl)3.5 ± 0.33.6 ± 0.43.6 ± 0.43.7 ± 0.4\<0.001Serum cholesterol (mg/dl)175.7 ± 41.7166.8 ± 39.5164.1 ± 38.4158.6 ± 39.4\<0.001BMI (kg/m^2^)29.3 ± 5.626.4 ± 4.824.8 ± 4.422.1 ± 3.3\<0.001Weight change over 12 mo (%)0 (−4.3, 3.0)−0.6 (−4.2, 3.6)0.2 (−3.2, 5.0)0.9 (−3.0, 4.7)0.005Body fat percentage40.2 ± 9.435.6 ± 9.032.4 ± 9.026.7 ± 7.7\<0.001MAMC (cm)26.4 ± 4.025.3 ± 3.824.4 ± 3.523.4 ± 3.1\<0.001Prevalence of PEW (%)12.319.722.337.7\<0.001[^7][^8]

Scatterplots relating baseline DPI, DEI, and enPCR with month 12 PEW syndrome variables are presented in [Figure 2](#fig2){ref-type="fig"}, [Figure 3](#fig3){ref-type="fig"}, [Figure 4](#fig4){ref-type="fig"}. Both DPI and DEI had an inverse relationship with body size, percentage of body fat, and mid-arm muscle circumference, whereas enPCR had weak positive relationship with body size and mid-arm muscle circumference.Figure 2Scatterplots of baseline dietary protein intake (DPI) with month 12 protein-energy wasting variables.Figure 3Scatterplots of baseline dietary energy intake (DEI) with month 12 protein-energy wasting variables.Figure 4Scatterplots of baseline equilibrated normalized protein catabolic rate (enPCR) with month 12 protein-energy wasting variables.

The prevalence of the PEW syndrome defined as the presence of at least 1 variable in 2 of the 3 categories (low serum chemistry, low body mass, and low muscle mass listed in [Table 1](#tbl1){ref-type="table"}) was 23.0% at the month 12 follow-up visit. The prevalence of the PEW syndrome at month 12 was 13.7% in the lowest baseline DPI quartile and the 39.4% in the highest baseline DPI quartile. In a multivariate logistic regression model, compared with those in the lowest baseline DPI quartile, those in the highest baseline DPI quartile had 4.11-fold (95% confidence interval: 2.79--6.05) higher odds of having the PEW syndrome at month 12 ([Figure 5](#fig5){ref-type="fig"}a). Similar relationships of the PEW syndrome with DEI quartiles were seen ([Figure 5](#fig5){ref-type="fig"}C).Figure 5Logistic regression models relating baseline dietary protein intake (DPI) and dietary energy intake (DEI) quartiles to the presence of the protein-wasting energy (PEW) syndrome at month 12 without (panels a and c) and with (panels b and d) adjustment for baseline body weight (N = 1487). (a,c) Model adjusted for baseline age, sex, race, duration of end-stage renal disease, dialysis access, Kt/V, flux group, smoking, alcohol use, diabetes, IHD, cerebrovascular disease, pulmonary vascular disease, congestive heart failure, cancer, and clinical center. (b,d) Model with additional adjustment for baseline postdialysis weight. CI = confidence interval; IHD = ischemic heart disease; OR = odds ratio.

This contrarian finding of lower risk of the PEW syndrome at month 12 in those with low baseline DPI and DEI could reflect mathematical coupling (because both DEI and DPI include body weight in the denominator and those with PEW have lower body weight). When the preceding logistic regression models were adjusted for baseline body weight, the previous associations were attenuated ([Figures 5](#fig5){ref-type="fig"}b and [5](#fig5){ref-type="fig"}d).

Similar results were obtained using regression models with cubic splines that did not require categorizing participants into quartiles. In spline regression models unadjusted for baseline body weight, there was an increase in the odds of having the PEW syndrome at month 12 with a higher baseline DPI or DEI ([Figures 6](#fig6){ref-type="fig"}a and [6](#fig6){ref-type="fig"}c), which was markedly attenuated when adjusted for baseline body weight ([Figures 6](#fig6){ref-type="fig"}b and [6](#fig6){ref-type="fig"}d).Figure 6Natural cubic spline regression models relating baseline dietary protein intake (DPI) and dietary energy intake (DEI) as continuous variables with the presence of the protein-wasting energy (PEW) syndrome at month 12 without and with adjusting for baseline body weight (N = 1487). (a,c) Model adjusted for baseline age, sex, race, duration of end-stage renal disease, dialysis access, Kt/V, flux group, smoking, alcohol use, diabetes, IHD, cerebrovascular disease, pulmonary vascular disease, congestive heart failure, cancer, and clinical center. (b,d) Model with additional adjustment for baseline postdialysis weight. CI = confidence interval; IHD = ischemic heart disease.

In additional analyses, we used enPCR as another measure of protein intake. Month 12 distribution of PEW variables and the prevalence of PEW syndrome by baseline quartiles of enPCR are presented in [Table 5](#tbl5){ref-type="table"}. Results of logistic regression models relating baseline enPCR quartiles and spline regression models relating enPCR as a continuous variable with the presence of the PEW syndrome at month 12 are shown in [Figure 7](#fig7){ref-type="fig"}. These results suggested that there was no relationship of baseline enPCR with PEW syndrome at month 12.Figure 7Logistic and spline regression models relating baseline equilibrated normalized protein catabolic rate (enPCR) to the presence of the protein-wasting energy (PEW) syndrome at month 12 without and with adjustment for baseline body weight (N = 1487). (a,c) Model adjusted for baseline age, sex, race, duration of end-stage renal disease, dialysis access, Kt/V, flux group, smoking, alcohol use, diabetes, IHD, cerebrovascular disease, pulmonary vascular disease, congestive heart failure, cancer, and clinical center. (b,d) Model with additional adjustment for baseline postdialysis weight. CI = confidence interval; IHD = ischemic heart disease.Table 5Month 12 distribution of PEW variables and the prevalence of PEW syndrome by baseline quartiles of enPCR (g/kg/d) (N = 1487)Lowest quartile\
\<0.87 (*n* = 372)2nd quartile\
0.87--1.01 (*n* = 371)3rd quartile\
1.02--1.18 (*n* = 371)Highest quartile\
≥1.18 (n = 373)*P* valueSerum albumin (g/dl)3.6 ± 0.43.6 ± 0.43.6 ± 0.43.7 ± 0.40.001Serum cholesterol (mg/dl)163.2 ± 40.8168.1 ± 41.7167.4 ± 39.4166.1 ± 38.90.41BMI (kg/m^2^)25.1 ± 5.025.7 ± 5.225.9 ± 5.625.9 ± 5.40.13Weight change over 12 mo (%)--0.3 (--4.1, 3.4)0 (--4.0, 3.9)0 (--3.5, 4.0)1.0 (--3.0, 5.0)0.15Body fat percentage33.6 ± 9.934.1 ± 9.634.2 ± 10.533.1 ± 10.30.54MAMC (cm)24.7 ± 3.925.0 ± 3.924.8 ± 3.524.9 ± 3.80.74Prevalence of PEW (%)24.5 ± 43.024.5 ± 43.120.8 ± 40.622.3 ± 41.60.55[^9][^10]

Discussion {#sec3}
==========

The current national guidelines recommend a DPI of 0.8 g/kg per day in the general population and 1.2 g/kg per day in patients on hemodialysis.[@bib29] The ISRNM panel used a conservative definition of \<0.8 g/kg per day as a PEW criterion for patients on MHD, with the expectation that for most patients on hemodialysis, the dietary protein requirements could be even higher. Hence, in this study we examined the relationships of baseline DPI and DEI with the PEW syndrome at month 12 using the quartiles of these variables at baseline. Interestingly, those in the highest quartile of DPI or DEI had a higher risk of the PEW syndrome. This was the result of mathematical coupling induced by the use of body weight as the denominator in the definition of DPI and DEI. However, when adjusted for baseline body weight, we still did not observe lower risk of PEW with higher baseline DPI or DEI ([Figure 5](#fig5){ref-type="fig"}). Similarly, we did not observe a relationship of low DPI or low DEI with increased odds of the PEW syndrome ([Figure 6](#fig6){ref-type="fig"}) in the spline regression models.

It could be argued that estimation of protein intake from 24-hour dietary recall is limited by reliance on memory and that the responses may be less accurate or unrepresentative of typical intakes.[@bib30] The accuracy of diet recalls can be questioned. For instance, the mean DEI of those who reported DEI of \<25 kcal/kg per day was only 17.3 ± 4.6 kcal/kg per day. The contradiction of stable body mass despite low reported DEI in patients on long-term hemodialysis has been previously studied; those who are overweight tend to under-report their calorie intake.[@bib31] Therefore, we also examined the associations of protein intake as estimated from urea kinetics with enPCR. Urea kinetics was carefully performed following a standardized protocol in the HEMO study because the dialysis dose intervention was based on Kt/V.[@bib22], [@bib23] However, we did not observe an association of low enPCR with an increased risk of PEW syndrome ([Figure 7](#fig7){ref-type="fig"}).

The ISRNM panel noted that depletion of protein or energy stores in kidney disease is not related to nutrient intake but rather is the result of wasting induced by hypercatabolism from multiple factors, including uremic toxins, inflammation, oxidative stress, and metabolic acidosis.[@bib19] The present analyses supported the concept that depleted protein and energy stores in patients on MHD might not be related to dietary intake.[@bib16], [@bib17], [@bib18]

The strengths of this study included the careful collection of data in the HEMO study and the detailed examination of protein and energy intakes as continuous and categorical variables, as well as different methodologies of protein intake assessment (dietary and urea kinetic modeling methods). The limitations of the study included the observational analysis of the existing trial data.

In summary, as a result of mathematical coupling, high baseline DPI or DEI is associated with increased odds of the PEW syndrome at follow-up in patients on MHD. Inclusion of these variables in the definition of the PEW syndrome will result in erroneous conclusions about the presence of the PEW syndrome.
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[^1]: BMI, body mass index; CKD, chronic kidney disease; DEI, dietary energy intake; DPI, dietary protein intake; MHD, maintenance hemodialysis.

[^2]: The International Society of Renal Nutrition and Metabolism serum albumin criterion was based on Bromocresol green (BCG) method measurement. In the HEMO study, serum albumin was measured by the nephelometry method, which is approximately 0.3 g/dl lower than that obtained with BCG method.[@bib20]

[^3]: DEI, dietary energy intake; DPI, dietary protein intake; enPCR, equilibrated normalized protein catabolic rate; ESRD, end-stage renal disease; TEI, total energy intake; TPI, total protein intake.

[^4]: Mean ± SD, % or median (25th, 75th percentiles) are presented.

[^5]: BMI, body mass index; DPI, dietary protein intake; MAMC, mid-arm mass circumference; PEW, protein-wasting energy.

[^6]: Mean ± SD, % or median (25th, 75th percentiles) are presented.

[^7]: BMI, body mass index; DEI, dietary energy intake; MAMC, mid-arm mass circumference; PEW, protein-wasting energy.

[^8]: Mean ± SD, % or median (25th, 75th percentiles) are presented.

[^9]: BMI, body mass index; enPCR, equilibrated normalized protein catabolic rate; MAMC, mid-arm mass circumference; PEW, protein-wasting energy.

[^10]: Mean ± SD, % or median (25th, 75th percentiles) are presented.
